Bacterial adherence and mucosal cytokine responses. Receptors and transmembrane signaling

Annals of the New York Academy of Sciences

Volumn 797, Issue , 1996, Pages 177-190

  Svanborg, Catharina ^a   Hedlund, Maria ^a   Connell, Hugh ^a   Agace, William ^a   Duan, Rui Dong ^a   Nilsson, Ake ^a   Wullt, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CELL RECEPTOR; CELL SURFACE RECEPTOR; CERAMIDE; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CELL ACTIVATION; CELL ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; LISTERIA; MUCOSA CELL; MUCOSA INFLAMMATION; NONHUMAN; NUTRIENT; SHIGELLA; SIGNAL TRANSDUCTION;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LISTERIA; SHIGELLA;

EID: 0030464896     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52959.x     Document Type: Conference Paper

References (49)

1. 1995. Signal transduction. Science 268: 221-251.
2. LEFFLER, H. & C. SVANBORG-EDÉN. 1980. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol. Lett. 8: 127-134.
3. HEDGES, S., W. AGACE & C. SVANBORG. 1995. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol. 3: 266-270.
4. AGACE, W., H. CONNELL & C. SVANBORG. 1996. Host resistance to urinary tract infection. In Urinary Tract Infection: Molecular Pathogenesis and Clinical Management. H. Mobley & J. Warren, Eds.: 221-243. American Society for Microbiology. Washington.
5. SVANBORG-EDÉN, C., L. HANSON, U. JODAL, U. LINDBERG & A. SOHL-ÅKELUND. 1976. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet 490-492.
6. MABECK, C., F. ØRSKOV & I. ØRSKOV. 1971. Escherichia coli serotypes and renal involvement in urinary-tract infection. Lancet 1: 1312-1314.
7. JOHNSON, J. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4: 80-128.
8. DE MAN, P., U. JODAL, K. LINCOLN & C. SVANBORG-EDÉN. 1988. Bacterial attachment and inflammation in the urinary tract. J. Infect. Dis. 158: 29-35.
9. LEFFLER, H. & C. SVANBORG-EDÉN. 1981. Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect. Immun. 34: 920-929.
10. VÄISÄNEN, R., J. ELO, L. TALLGREN, A. SIITONEN, P. MÄKELÄ, C. SVANBORG-EDÉN, G. KÄLLENIUS, S. SVENSON, H. HULTBERG & T. KORHONEN. 1981. Mannose resistant haemagglutination and P antigen recognition characteristics of Escherichia coli causing primary pyelonephritis. Lancet ii: 1366-1369.
11. HAGBERG, L., R. HULL, S. HULL, S. FALKOW, R. FRETER & C. SVANBORG-EDÉN. 1983. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect. Immun. 40: 265-272.
12. SVANBORG-EDÉN, C., L. HAGBERG, R. HULL, S. HULL, K.-E. MAGNUSSON, L. ÖHMAN. 1987. Bacterial virulence versus host resistance in the urinary tracts of mice. Infect. Immun. 55: 1224-1232.
13. LINDER, H., I. ENGBERG, H. HOSCHÜTZKY, I. MATTSBY BALTZER & C. SVANBORG-EDÉN. 1991. Adhesin dependent activation of mucosal IL-6 production. Infect. Immun. 59: 4357-4362.
14. ROBERTS, J., B.-I. MARKLUND, D. ILVER, M. HASLAM, G. KAAK, G. BASKIN, R. MÖLLBY, J. WINBERG & S. NORMARK. 1994. The Galα(1-4)Gal specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc. Natl. Acad. Sci. USA 91: 11889-11893.
15. WINBERG, J., R. MÖLLBY, J. BERGSTRÖM, K.-A. KARLSSON, I. LEONARDSSON, M. MILH, S. TENEBERG, D. HASLAM, B.-I. MARKLUND & S. NORMARK. 1995. The PapG-adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infections of Cynomolgus monkeys. J. Exp. Med. 182: 1695-1702.
16. BOCK, K., M. BREIMER, A. BRIGNOLE, G. HANSSON, K.-A. KARLSSON, G. LARSSON, H. LEFFLER, B. SAMUELSSON, N. STRÖMBERG, C. SVANBORG-EDÉN & J. THURIN. 1985. Specificity of binding of a strain of uropathogenic Escherichia coli to Galα1-4Galβ containing glycosphingolipids. J. Biol. Chem. 260: 8545-8551.
17. BREIMER, M., G. HANSSON & H. LEFFLER. 1985. The specific glycosphingolipid composition of human urethral epithelial cells. J. Biochem. 98: 1169-1180.
18. LOMBERG, H., B. CEDERGREN, H. LEFFLER, B. NILSSON, A.-S. CARLSTRÖM & C. SVANBORG-EDÉN. 1986. Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli. Infect. Immun. 51: 919-926.
19. LINDSTEDT, R., G. LARSON, P. FALK, U. JODAL, H. LEFFLER & C. SVANBORG. 1991. The receptor repertoire defines the host range for attaching E. coli recognizing globo-A. Infect, Immun. 59: 1086.
20. LINDBERG, F., B. LUND, L. JOHANSSON & S. NORMARK. 1987. Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature 328: 84-87.
21. LUND, B., B.-I. MARKLUND, N. STRÖMBERG, F. LINDBERG, K. KARLSSON & S. NORMARK. 1988. Uropathogenic Escherichia coli can express serologically identical pili of different receptor binding specificities. Mol. Microbiol. 2: 255-263.
22. STRÖMBERG, N., B.-I., MARKLUND, B. LUND, D. ILVER, A. HAMERS, W. GAASTRA, K.-A. KARLSSON & S. NORMARK. 1990. Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Galα-4Galβ-containing isoreceptors. EMBO J. 9: 2001-2010.
23. LINDSTEDT, R., P. FALK, R. HULL, S. HULL, H. LEFFLER, C. SVANBORG-EDÉN & G. LARSON. 1989. Binding specificities of wild-type and cloned Escherichia coli strains that recognize globo-A. Infect. Immun. 57: 3389-3394.
24. JOHANSON, I., R. LINDSTEDT & C. SVANBORG. 1992. The role of the pap and prs encoded adhesins in Escherichia coli adherence to human epithelial cells. Infect. Immun. 60: 3416-3422.
25. PLOS, K., T. CARTER, S. HULL, R. HULL & C. SVANBORG-EDÉN. 1990. Frequency and organisation of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli. J. Infect. Dis. 161: 518-524.
26. JOHANSON, I.-M., K. PLOS, B.-I. MARKLUND & C. SVANBORG. 1993. Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microbial Path. 15: 121-129.
27. DE MAN, P., C. VAN KOOTEN, L. AARDEN, I. ENGBERG & C. SVANBORG-EDÉN. 1989. Interleukin-6 induced by Gram-negative bacterial infection at mucosal surfaces. Infect. Immun. 57: 3383-3388.
28. HEDGES, S., P. ANDERSON, G. LIDIN-JANSON, P. DE MAN & C. SVANBORG. 1991. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect. Immun. 59: 421-427.
29. HEDGES, S., K. STENQUIST, G. LIDIN-JANSON, J. MARTINELL, T. SANDBERG & C. SVANBORG. 1992. Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria. J. Infect. Dis. 166: 653-656.
30. BENSON, M., U. JODAL, W. AGACE, M. HELLSTRÖM, S. MARILD, S. ROSBERG, M. SJÖSTRÖM, B. WETTERGREN, S. JONSON & C. SVANBORG. 1996. J. Infect. Dis., Nov. issue. In press.
31. LINDBERG, U. 1975. Asymptomatic bacteriuria in school girls. V. The clinical course and response to treatment. Acta Paediatr. Scand. 64: 718-724.
32. HANSSON, S., D. CAUGANT, U. JODAL & C. SVANBORG-EDÉN. 1989. Untreated asymptomatic bacteriuria in girls. I. Stability of urinary isolates. Brit. Med. J. 298: 853-855.
33. HAGBERG, L., A. BRUCE, G. REID, C. SVANBORG-EDÉN, K. LINCOLN & G. LIDIN-JANSON. 1986. Colonisation of the urinary tract with bacteria from the normal fecal and urethral flora in patients with recurrent urinary tract infections. In Host-Parasite Interactions in Urinary Tract Infections. E. Kass & C. Svanborg-Edén, Eds.: 194-297. Chicago Press. Chicago.
34. ANDERSON, P., I. ENGBERG, G. LIDIN-JANSON, K. LINCOLN, R. HULL, S. HULL & C. SVANBORG-EDÉN. 1991. Persistence of Escherichia coli bacteriuria not determined by bacterial adherence. Infect. Immun. 59: 2915-2921.
35. HEDGES, S., M. SVENSSON & C. SVANBORG. 1992. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect. Immun. 60: 1295-1301.
36. HEDGES, S., P. DE MAN, H. LINDER, C. VAN KOOTEN & C. SVANBORG-EDÉN. 1990. Interleukin-6 is secreted by epithelial cells in response to Gram-negative bacterial challenge. In Advances in Mucosal Immunology, International Conference of Mucosal Immunity. T. MacDonald, Ed.: 144-148. Kluwer. London.
37. AGACE, W., S. HEDGES, M. CESKA & C. SVANBORG. 1993. IL-8 and the neutrophil response to mucosal Gram negative infection. J. Clin. Invest. 92: 780-785.
38. SVENSSON, M., R. LINDSTEDT, N. RADIN & C. SVANBORG. 1994. Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production. Infect. Immun. 62: 4404-4410.
39. SCHÜTZE, S., K. POTTHOFF, T. MACHLEIDT, C. BERKOVIC, K. WIEGMAN & M. KRÖNKE. 1992. TNF activates NK-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71: 765-776.
40. MATHIAS, S., A. YOUNES, C. KAN, I. ORLOW, C. JOSEPH & R. KOLESNICK. 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science (Wash., DC). 259: 519-522.
41. CIFONE, M., R. DE MARIA, P. RONCAIOLI, M. RIPPO, M. AZUMA, L. LANIER, A. SANTINI & R. TESTI. 1993. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 177: 1547-1552.
42. MATHIAS, S., K. DRESSLER & R. KOLESNICK. 1991. Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor a. Proc. Natl. Acad. Sci. USA 88: 10009-10013.
43. DOBROWSKY, R. & Y. HANNUN. 1993. Ceramide-activated protein phosphatase: Partial purification and relationship to protein phosphatase 2A. Adv. Lipid Res. 25: 91-104.
44. HEDLUND, M., M. SVENSSON, A. NILSSON, R.-D. DUAN & C. SVANBORG. 1996. Role of the ceramide signalling pathway in cytokine responses to P fimbriated Escherichia coli. J. Exp. Med. 183: 1-8.
45. GATT, S. 1976. Magnesium-dependent sphingomyelinase. Biochem. Biophys. Acta 68: 235-241.
46. KOLESNICK, R. 1991. Sphingomyelin and derivatives as cellular signals. Prog. Lipid. Res. 30: 1-38.
47. JOSEPH, C., S. WRIGHT, W. BORNMANN, J. RANDOLPH, E. KUMAR, R. BITTMAN, J. LIU & R. KOLESNICK. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269: 17606-17610.
48. LINDER, H., I. ENGBERG, I. MATTSBY BALTZER, K. JANN & C. SVANBORG-EDÉN. 1988. Induction of inflammation by Escherichia coli on the mucosal level: Requirement for adherence and endotoxin. Infect. Immun. 56: 1309-1313.
49. HOSCHÜTZKY, H., F. LOTTSPEICH & K. JANN. 1989. Isolation and characterization of the alpha-galactosyl-1,4-beta-galactosyl-specific adhesin (P-adhesin) from fimbriated Escherichia coli. Infect. Immun. 57: 76-81.